Q1 2025 Holdings
Filed 2025-05-15 | 51 holdings | $2.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $771.7M | 19,751,284 | 31.5% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $197.1M | 1,690,221 | 8.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $176.2M | 4,982,384 | 7.2% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $141.3M | 5,161,801 | 5.8% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $126.0M | 2,796,513 | 5.1% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $124.5M | 2,575,015 | 5.1% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $97.4M | 8,827,712 | 4.0% |
| Xoma Royalty Corporation(XOMA) | COM NEW | 98419J206 | $59.5M | 2,983,026 | 2.4% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $57.7M | 1,913,385 | 2.4% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $51.3M | 4,308,935 | 2.1% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $51.2M | 7,754,129 | 2.1% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $43.5M | 5,750,683 | 1.8% |
| AC Immune SA(ACIU) | SHS | H00263105 | $37.1M | 19,822,436 | 1.5% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $36.7M | 3,944,194 | 1.5% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $36.5M | 1,454,422 | 1.5% |
| Celcuity Inc(CELC) | COM | 15102K100 | $35.0M | 3,466,000 | 1.4% |
| Verve Therapeutics Inc | COM | 92539P101 | $31.6M | 6,904,050 | 1.3% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $30.7M | 1,771,417 | 1.2% |
| Xencor Inc(XNCR) | COM | 98401F105 | $29.2M | 2,740,141 | 1.2% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $26.3M | 5,660,132 | 1.1% |
| Septerna Inc(SEPN) | COM | 81734D104 | $25.5M | 4,396,124 | 1.0% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $21.3M | 6,293,282 | 0.9% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $19.9M | 924,642 | 0.8% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $19.9M | 5,295,893 | 0.8% |
| Palvella Therapeutics Inc NE(PVLA) | COM | 697947109 | $19.5M | 696,555 | 0.8% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $19.4M | 5,302,000 | 0.8% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $18.4M | 3,075,000 | 0.7% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $14.7M | 4,561,289 | 0.6% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $13.8M | 8,748,629 | 0.6% |
| Annexon Inc(ANNX) | COM | 03589W102 | $13.5M | 7,000,000 | 0.6% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $12.7M | 2,100,468 | 0.5% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $11.3M | 9,237,556 | 0.5% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $10.2M | 10,333,600 | 0.4% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $9.7M | 8,902,972 | 0.4% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $8.3M | 1,036,679 | 0.3% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $8.2M | 2,372,933 | 0.3% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $7.1M | 4,013,633 | 0.3% |
| Tscan Therapeutics Inc(TCRX) | COM | 89854M101 | $6.7M | 4,889,474 | 0.3% |
| Molecular Partners AG(MOLN) | ADS | 60853G106 | $5.5M | 1,353,968 | 0.2% |
| Ikena Oncology Inc | COM | 45175G108 | $5.1M | 4,006,564 | 0.2% |
| Forte Biosciences Inc(FBRX) | COM NEW | 34962G208 | $4.6M | 594,282 | 0.2% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $3.8M | 16,552,417 | 0.2% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $3.3M | 5,228,461 | 0.1% |
| Tenax Therapeutics Inc(TENX) | COM NEW | 88032L605 | $2.2M | 339,549 | 0.1% |
| Inventiva SA(IVA) | ADS | 46124U107 | $2.1M | 686,040 | 0.1% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $2.0M | 9,544,262 | 0.1% |
| SAB Biotherapeutics Inc(SABS) | COM NEW | 78397T202 | $1.2M | 917,826 | 0.1% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $1.2M | 59,065 | 0.0% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $1.2M | 3,853,818 | 0.0% |
| Engene Holdings Inc(ENGNW) | *W EXP 10/31/202 | 29286M113 | $605.1K | 945,402 | 0.0% |